Candela Corporation (NASDAQ:CLZR) announced that it has received registration approval from the Brazilian National Health Surveillance Agency (ANVISA) to market the Candela Alex TriVantage® multi-wavelength, q-switched laser system in Brazil.

"Until now, providing high quality and effective treatment for pigmented lesions and multi-color tattoos meant that Brazilian doctors needed to own at least two different lasers. With Alex TriVantage's Laser-Pumped-Laser (LPL) technology, a greater number of doctors will be able to offer a wider variety of services assured of the ability to provide treatment regardless of the patient's skin color," said Candela President and Chief Executive Officer, Gerard E. Puorro. "This approval increases the number of Candela products marketed in Brazil, enabling us to offer a more complete range of highly effective aesthetic laser solutions."

Unique, q-switched Laser-Pumped-Laser (LPL) technology provides 755 nm, 532 nm and 1064 nm output wavelengths, making Alex TriVantage extremely versatile. The addition of a long-pulse mode at 755nm offers advanced treatments for a wider variety of pigmented lesions without side effects. Beyond the treatment of benign pigmented lesions and the removal of multi-color tattoo inks, Alex TriVantage enhances the results of many skin rejuvenation treatments, making it an ideal system for optimizing fractional and other rejuvenation treatment results.

The Alex TriVantage platform has received wide acclaim including a recent feature on ABC's nationally broadcasted "The View". To see dermatologist Suzanne Kilmer, MD from Sacramento, CA performing a tattoo removal treatment, visit Candela's website at http://www.candelalaser.com/theview.

Source
Candela Corporation